MEDCast

Achieving Superior Treatment Durability and Outcomes in Neovascular AMD and DME

Oct 31, 2023, 02:55 PM

Expert retina specialists discuss the latest therapies that could reduce the treatment burden and provide superior clinical outcomes in retinal diseases.

Audioboom uses Javascript

Please enable it in your browser's preferences.

You can visit our support center if you're having problems.

Sorry, your browser isn't supported by Audioboom.

We recommend upgrading to the latest Chrome, Firefox, Safari, or Edge.

You can visit our support center if you're having problems.

Achieving Superior Treatment Durability and Outcomes in Neovascular AMD and DME

Subscribe

Next

Creating Hope and Providing Better Treatment Options for Schizophrenia

Top episodes

Paradigm Shift in Parkinson’s Disease Diagnosis

Faricimab versus High-Dose Aflibercept for the Treatment of Neovascular AMD and DME

Generational Trends and Innovations in Retinal Disease Care

Sorry, your browser isn't supported by Audioboom.

Page load failed